Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma

被引：0
|
作者：
Laidlaw, Grace [1 ]
Gao, Rebecca [1 ]
Ayers, Kelsey [2 ]
Backhus, Leah [2 ]
Berry, Mark [2 ]
Shrager, Joseph [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Cardiothorac Surg, Stanford, CA 94305 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
EGFR; lung adenocarcinoma; sublobar resection;
D O I：
10.1016/j.jtho.2016.11.1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.08-033
引用
收藏
页码：S751 / S751
页数：1
相关论文
共 50 条
  • [21] HER-2 Mutations in Chinese Lung Adenocarcinoma Patients with Negative EGFR Mutations
    Zhou, Caicun
    Li, Xuefei
    Zhao, Chao
    Ren, Shengxiang
    Su, Chunxia
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S705 - S705
  • [22] Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
    Hofman, P.
    Ilie, M.
    Hofman, V.
    Roux, S.
    Valent, A.
    Bernheim, A.
    Alifano, M.
    Leroy-Ladurie, F.
    Vaylet, F.
    Rouquette, I.
    Validire, P.
    Beau-Faller, M.
    Lacroix, L.
    Soria, J. C.
    Fouret, P.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1738 - 1743
  • [23] Detecting EGFR Mutations from Plasma cfDNA in Lung Adenocarcinoma Patients
    Hung, M.
    Lung, J.
    Lin, Y.
    Fang, Y.
    Tsai, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment
    Shen, Hong
    Zhong, Xian
    Ge, Xiao-qin
    Huang, Jian-Jin
    Yuan, Ying
    CLINICAL RESPIRATORY JOURNAL, 2010, 4 (03): : 192 - 193
  • [25] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [26] EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAPP)
    Cardona, A.
    Ruiz-Patino, A.
    Castro, C.
    Rojas, L.
    Arrieta, O.
    Zatarain-Barron, Z.
    Carranza, H.
    Vargas, C.
    Otero, J.
    Corrales, L.
    Martin, C.
    Rosell, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S802 - S802
  • [27] Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates
    Sacconi, B.
    Anzidei, M.
    Leonardi, A.
    Boni, F.
    Saba, L.
    Scipione, R.
    Anile, M.
    Rengo, M.
    Longo, F.
    Bezzi, M.
    Venuta, F.
    Napoli, A.
    Laghi, A.
    Catalano, C.
    CLINICAL RADIOLOGY, 2017, 72 (06) : 443 - 450
  • [28] Clinical Features and Progression Free Survival of Lung Adenocarcinoma Patients with EGFR sensitizing mutations with Dose Reduction of Afatinib
    Angasreni, W.
    Andarini, S. L.
    Zaini, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S641 - S642
  • [29] EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)
    Alejandro Ruiz-Patiño
    Christian David Castro
    Luisa María Ricaurte
    Andrés F. Cardona
    Leonardo Rojas
    Zyanya Lucia Zatarain-Barrón
    Beatriz Wills
    Noemí Reguart
    Hernán Carranza
    Carlos Vargas
    Jorge Otero
    Luis Corrales
    Claudio Martín
    Pilar Archila
    July Rodriguez
    Jenny Avila
    Melissa Bravo
    Luis Eduardo Pino
    Rafael Rosell
    Oscar Arrieta
    Targeted Oncology, 2018, 13 : 621 - 629
  • [30] EGFR Amplification and Sensitizing Mutations Correlate with Survival in Lung Adenocarcinoma Patients Treated with Erlotinib (MutP-CLICaP)
    Ruiz-Patino, Alejandro
    David Castro, Christian
    Maria Ricaurte, Luisa
    Cardona, Andres F.
    Rojas, Leonardo
    Lucia Zatarain-Barron, Zyanya
    Wills, Beatriz
    Reguart, Noemi
    Carranza, Hernan
    Vargas, Carlos
    Otero, Jorge
    Corrales, Luis
    Martin, Claudio
    Archila, Pilar
    Rodriguez, July
    Avila, Jenny
    Bravo, Melissa
    Eduardo Pino, Luis
    Rosell, Rafael
    Arrieta, Oscar
    TARGETED ONCOLOGY, 2018, 13 (05) : 621 - 629
12345